Indonesia allows Taiwan's COVID-19 vaccine candidate to conduct clinical trial
09/13/2021 12:05 PM
Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results expected to be released next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan congratulates Leo XIV on being elected new pope
05/09/2025 12:29 PM - Society
KMT Keelung branch chairman detained in recall probe
05/09/2025 10:50 AM - Business
U.S. dollar up in Taipei trading
05/09/2025 10:11 AM - Society
Taiwan headline news
05/09/2025 09:35 AM - Business
Taiwan shares open higher
05/09/2025 09:07 AM